Skip to main content
Clinical Trials/NCT02696694
NCT02696694
Completed
Not Applicable

Impact of Serum Progesterone Levels on the Day of Embryo Transfer on the Success Rate in Egg Donation Cycles Under Hormonal Replacement

Instituto Valenciano de Infertilidad, IVI VALENCIA1 site in 1 country242 target enrollmentFebruary 2016
ConditionsPregnancy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy
Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Enrollment
242
Locations
1
Primary Endpoint
mid-luteal serum progesterone level
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This study aims to investigate the impact of serum progesterone concentrations on the day of embryo transfer in egg donation cycles under hormonal replacement therapy. As secondary outcomes, the investigators will investigate if endometrial volume measured by three-dimensional (3D) ultrasound on the day of embryo transfer is related with progesterone levels and with chances of pregnancy.

Registry
clinicaltrials.gov
Start Date
February 2016
End Date
October 2016
Last Updated
9 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Responsible Party
Principal Investigator
Principal Investigator

Elena Labarta

Elena Labarta, MD, PhD

Instituto Valenciano de Infertilidad, IVI VALENCIA

Eligibility Criteria

Inclusion Criteria

  • Age\<50 yo
  • BMI \< 30Kg/m2
  • Hormonal replacement cycle
  • Endometrial thickness \>6.5 mm during proliferative phase
  • Transfer of one or two blastocyst grade A-B according to ASEBIR

Exclusion Criteria

  • Uterine pathology
  • Cryptozoospermia
  • Severe implantation failure (\>6 GQ embryos transferred without success)

Outcomes

Primary Outcomes

mid-luteal serum progesterone level

Time Frame: one year

Secondary Outcomes

  • endometrial volume(one year)

Study Sites (1)

Loading locations...

Similar Trials